You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 5,192,507


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,192,507
Title: Receptor-based biosensors
Abstract:A method of immobilizing and stabilizing an active biological receptor in a polymeric film and receptor-based biosensors for determining an analyte of interest in a sample. The receptor-based biosensors include a polymeric film having a biological receptor capable of binding an analyte of interest immobilized therein according to the method of the present invention and an electrical means for determining the presence and quantity of the analyte. In particular, acetylcholine receptor and opiate receptor have been immobilized in a polymeric film made by combining the receptor, a material (e.g., bovine serum albumin, gelatin) capable of polymerizing and a polymerizing agent (e.g., glutaradehyde).
Inventor(s): Taylor; Richard F. (W. Boxford, MA), Marenchic; Ingrid G. (Walpole, MA), Cook; Edward J. (South Hamilton, MA)
Assignee: Arthur D. Little, Inc. (Cambridge, MA)
Application Number:07/664,440
Patent Claims:1. An opiate receptor-containing biosensor for the determination of an opiate in a sample comprising:

a) a polymeric film formed by chemical copolymerization of a solution comprising:

1) a base component which is a protein,

2) an opiate receptor; and

3) at least one stabilizer selected from the group consisting of lipids, detergents and antioxidants;

b) a first sensor comprising a first conductor and a second conductor which are in contact with said film; and

c) a current source in conductive contact with the first and second conductors for measuring an electrical characteristic of the polymeric film.

2. An opiate receptor-containing biosensor of claim 1 wherein the protein is selected from the group consisting of serum albumin, gelatin and collagen.

3. An opiate receptor-containing biosensor of claim 1 wherein the lipid is selected from the group consisting of: phosphatidyl choline and cholesteryl palmitate, the detergent is selected from the group consisting of octylphenoxy polyethoxethanol, sodium cholate, cetyltrimethyl-ammonium bromide, polyoxyethylene, sorbitan monooleate, N-decyl-N-dimethyl-3-ammonio-1-propane sulfonate and N-octyl-N-dimethyl-3-ammonio-1-propane sulfonate, and the antioxidant is selected from the group consisting of alphatocopherol and butylated hydroxyanisole.

4. A double chip, opiate receptor-containing biosensor for the determination of an opiate in a sample, comprising a first polymeric film comprising a protein, a stabilizer and an opiate receptor, the first polymeric film being in contact with a first electrical sensor for measuring an electrical characteristic of the first polymeric film and further comprising:

a) a second nonreceptor containing polymeric film, the second polymeric film being in contact with a second electrical sensor for measuring an electrical characteristic of the second polymeric film;

b) a potential barrier interposed between the second nonreceptor containing film and the first polymeric film, such that the barrier hinders current flow between said second nonreceptor containing film and the first polymeric film;

c) a current source; and

d) a circuit contacting the current source and the first and the second electrical sensors for measuring the absolute and the differential changes in the electrical characteristics of the first and second films.

5. An opiate receptor-containing biosensor of claim 1 wherein the protein is selected from the group consisting of serum albumin, gelatin and collagen.

6. An opiate receptor-containing biosensor of claim 4 wherein the lipid is selected from the group consisting of: phosphatidyl choline and cholesteryl palmitate, the detergent is selected from the group consisting of octylphenoxy polyethoxethanol, sodium cholate, cetyltrimethyl-ammonium bromide, polyoxyethylene, sorbitan monooleate, N-decyl-N-dimethyl-3-ammonio-1-propane sulfonate and N-octyl-N-dimethyl-3-ammonio-1-propane sulfonate, and the antioxidant is selected from the group consisting of alphatocopherol and butylated hydroxyanisole.

7. A method of immobilizing and stabilizing an opiate receptor in a polymeric film on a transducer, comprising:

a. forming a mixture by combining an opiate receptor, a base component which is a protein, a polymerizing agent and at least one stabilizer selected from the group consisting of lipids, detergents and antioxidants, under conditions appropriate for polymerization to occur; and

b. forming a film by polymerization of the mixture of a) on the transducer.

8. A method of claim 7 wherein the base component is selected from the group consisting of bovine serum albumin, human serum albumin, gelatin and collagen; the polymerizing agent is glutaraldehyde; the lipid is selected from the group consisting of: phosphatidyl choline and cholesteryl palmitate, the detergent is selected from the group consisting of octylphenoxy polyethoxethanol, sodium cholate, cetyltrimethylammonium bromide, polyoxyethylene, sorbitan monooleate, N-decyl-N-dimethyl-3-ammonio-1-propane sulfonate and N-octyl-N-dimethyl-3-ammonio-1-propane sulfonate, and the antioxidant is selected from the group consisting of alphatocopherol and butylated hydroyanisole.

9. A method for determining the presence of an opiate in a sample comprising:

a) contacting the sample with a biosensor comprising:

1) a polymeric film formed by chemical copolymerization of a solution comprising:

a) a base component which is a protein;

b) an opiate receptor capable of binding the analyte; and

c) at least one stabilizer selected from the group consisting of lipids, detergents and antioxidants; and

2) a sensor comprising a first conductor and a second conductor which are in contact with the polymeric protein film; and

b) determining a change in the electrical characteristic of the polymeric protein film, whereby a change is indicative of the presence of analyte in the sample.

Details for Patent 5,192,507

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2007-06-05
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2007-06-05
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2007-06-05
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 08/15/1978 ⤷  Try a Trial 2007-06-05
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 02/17/1995 ⤷  Try a Trial 2007-06-05
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 06/11/2003 ⤷  Try a Trial 2007-06-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.